Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.11 | €3.00 | 42.518% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 2 | €1.07 | €2.00 | 86.480% |
| Medigene AG | 0 | 2 | 0 | 0 | €1.51 | €1.00 | -33.775% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.64 | - | - |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.09 | €3.65 | 236.206% |
| Novavax Inc. | 4 | 2 | 1 | 0 | €4.52 | €12.00 | 165.369% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.32 | €0.000 | -100.000% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.58 | €15.50 | 23.282% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €40.90 | €67.64 | 65.377% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.96 | €26.71 | 106.133% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.64 | €3.00 | 369.778% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.90 | €7.00 | 1.449% |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.92 | - | - |
| Fibrogen Inc. | 1 | 4 | 0 | 0 | €1.05 | €0.000 | -100.000% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.26 | €7.00 | 209.735% |
| Ionis Pharmaceuticals Inc. | 17 | 5 | 4 | 0 | €39.23 | €56.86 | 44.945% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.84 | €8.82 | 955.999% |
| Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.97 | €3.00 | 210.238% |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.54 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.53 | €2.79 | 428.947% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Trevena Inc. | 1 | 14 | 0 | 3 | €0.35 | €8.37 | 2263.390% |